Trial Profile
Multicentre, Retrospective Long-Term Outcomes Trial of Adalimumab Therapy in Ulcerative Colitis Patients by Prior Anti-Tnf Exposure
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Oct 2017
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 11 Mar 2016 New trial record